Evidence map›Paper›PMID 33585700›Full record

ArticleOpen medicine (Warsaw, Poland)2021

An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers.

Chih-Yen Chang, Yen-Chiao Angel Lu, Wen-Chien Ting, Tsu-Wang David Shen, Wen-Chen Peng

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Chih-Yen ChangDepartment of Medical Education and Research, Jen-Ai Hospital, Taichung, Taiwan.
Yen-Chiao Angel LuSchool of Nursing, College of Medicine, Chung-Shan Medical University, Taichung, Taiwan.
Wen-Chien TingDivision of Colorectal Surgery, Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan.
Tsu-Wang David ShenDepartment of Automatic Control Engineering, Feng Chia University, No. 100, Wenhwa Road, Seatwen, Taichung, 40724, Taiwan.
Wen-Chen PengDepartment of Long-Term Care, Jen-Ai hospital, Taichung, Taiwan.
Jen-Ai Hospital · TWChung Shan Medical University · TWChung Shan Medical University Hospital · TWFeng Chia University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial cancer is one of the most common gynecological malignancies in developed countries. The prevention of the recurrence of endometrial cancer has always been a clinical challenge. Endometrial cancer is asymptomatic in the early stage, and there remains a lack of time-series correlation patterns of clinical pathway transfer, recurrence, and treatment. In this study, the artificial immune system (AIS) combined with bootstrap sampling was compared with other machine learning techniques, which included both supervised and unsupervised learning categories. The back propagation neural network, support vector machine (SVM) with a radial basis function kernel, fuzzy c-means, and ant k-means were compared with the proposed method to verify the sensitivity and specificity of the datasets, and the important factors of recurrent endometrial cancer were predicted. In the unsupervised learning algorithms, the AIS algorithm had the highest accuracy (83.35%), sensitivity (77.35%), and specificity (92.31%); in supervised learning algorithms, the SVM algorithm had the highest accuracy (97.51%), sensitivity (95.02%), and specificity (99.29%). The results of our study showed that histology and chemotherapy are important factors affecting the prediction of recurrence. Finally, behavior code and radiotherapy for recurrent endometrial cancer are important factors for future adjuvant treatment.

Indexed as

artificial immune systemsbiomimetic intelligencebootstrap samplingrecurrent endometrial cancers

Identifiers

PMID33585700
PMCPMC7863001
OpenAlexW3128189998

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.